In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Stem cells are often described as the body's master cells. Healthy stem cells can restore the blood system after cancer ...

These events are associated with innate training and can have long-term impacts on hematopoietic stem and progenitor cell (HSPC) development but can also compromise their function. While many ...

A treatment that could replenish cells in the brains of Parkinson’s disease patients caused no major negative reactions in ...

The ACCESS trial is a multicenter, phase 2 trial designed to compare overall survival in patients receiving mismatched unrelated donor peripheral blood stem cells as an allograft source for ...

Market Valued at US$ 1.69 Billion in 2024, Driven by Technological Advancements and Growing Healthcare Investments ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

U.S. Physician to win the Steven E. Weinberger Award for Physician Executives/Leaders by the American College of Physicians ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Dr. Aljurf is the first recipient from outside the United States, underscoring his global impact on hematopoietic stem cell ...

interactive map of U2OS cells, which are associated with pediatric bone tumors. They combined high-resolution microscope imaging and biophysical interactions of proteins to map the subcellular ...